CLINICAL_TRIALS
trial_result
· 2026-04-13
Clinical Trial Update: A Study of XmAb23104 in People With Sarcoma [Phase 2]
Summary
A Phase 2 study of XmAb23104 in patients with sarcoma was terminated and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2026-04-13